Henry Wilson

Henry Wilson has extensive work experience in the field of antibody development and therapeutic research. Henry currently works as a Principal Scientist at Auron Therapeutics since 2022. Prior to that, they spent three years at Pfizer as a Principal Scientist, leading a project focused on therapeutic antibody development for immunology/inflammation. During their time at Pfizer, they also held the position of Senior Scientist, where they were responsible for antibody discovery, optimization, and engineering. Before joining Pfizer, Henry worked as a Graduate Student at The Scripps Research Institute, where their thesis focused on target identification for monoclonal antibody-based therapy of cancer. Overall, their experience includes antibody characterization, cross-functional collaboration, NGS-based analysis, and the development of antibody drug and target discovery platforms.

Henry Wilson earned their Bachelor's Degree in Biophysics from the University of Michigan from 2008 to 2012. Henry then pursued a Doctor of Philosophy (Ph.D.) in Biochemistry at Scripps Research from 2013 to 2019. In addition, they obtained certifications in "Data Visualization & Dashboarding with R" from Coursera and "Applied Data Science" from the Massachusetts Institute of Technology in 2022 and 2021 respectively.